Large Molecule Bioanalysis done differently

To help you achieve more.

BioAgilytix has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

usa europe labs

Advanced facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • Today Agoview on linkedin


    Rely on the combined power of BioAgilytix’s veteran scientists, advanced platforms, and validated techniques to quickly progress the development of your promising biosimilars. Speak to one of our scientists today to learn more.

  • 3 Days Agoview on linkedin


    Our strategic partnership with ATCC allows us to be a true end-to-end partner cell-based assay development, offering resources to access, develop, characterize, and store cell lines, and to develop, validate, and perform the robust cell-based assays in which they will be used.

  • 3 Days Agoview on linkedin


    Our scientists are key to the quality of work that BioAgilytix produces, proactively helping our customers problem-solve through every phase of large molecule drug development. Meet some of our experts here: